Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders

Details for Australian Patent Application No. 2007324702 (hide)

Owner Epigenomics AG

Inventors Payne, Shannon; Tetzner, Reimo; Distler, Jurgen; Dietrich, Dimo; Sledziewski, Andrew; Model, Fabian; Lofton-Day, Catherine

Agent Pizzeys

Pub. Number AU-A-2007324702

PCT Pub. Number WO2008/061801

Priority 06124746.6 24.11.06 EP

Filing date 26 November 2007

Wipo publication date 29 May 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/061801 Priority application(s): WO2008/061801

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007324705-Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production

2007324696-N- (methyl) -1Hpyrazol3 -amine, N- (methyl) -pyridin-2-amine and N- (methyl) -thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. Alzheimer's